Raf inhibitor 1 25 mg | 98.05%
TargetMol
Raf inhibitor 1
Search Results
Raf inhibitor 1 2 mg | 98.05%
TargetMol
Raf inhibitor 1
Mutant IDH1-IN-1 1 mg | 98.98%
TargetMol
Mutant IDH1-IN-1 is a potent mutant IDH1 R132 h inhibitor with IC50 < 0.1 uM.
More Information Supplier PageMutant IDH1-IN-1
CTX-0294885 100 mg | 99.95%
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information Supplier PageCTX-0294885
CTX-0294885 25 mg | 99.95%
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information Supplier PageCTX-0294885
SB-431542 200 mg | 99.87%
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information Supplier PageSB-431542
SB-431542 25 mg | 99.87%
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information Supplier PageSB-431542
5-Amino-4-imidazolecarboxamide 100 mg | 100.00%
TargetMol
5-Amino-4-imidazolecarboxamide
IBMX 200 mg | 99.76%
TargetMol
IBMX is a pan-phosphodiesterase (PDE) inhibitor (IC50s: 6.5/26.3/31.7 μM for PDE3/PDE4/PDE5).
More Information Supplier PageIBMX
IBMX 100 mg | 99.76%
TargetMol
IBMX is a pan-phosphodiesterase (PDE) inhibitor (IC50s: 6.5/26.3/31.7 μM for PDE3/PDE4/PDE5).
More Information Supplier PageIBMX